Last Updates CinnaGen Co. pioneers Iran’s pharmaceutical export IRNA: Dr. Mohammad Reza Monazzam, Manager of Health Technology Development and Industrial Relationship Office, announced that “this is a big honor for country’s high-tech health industries that Cinnagen and Aryogen have been chosen from 1100 assessed companies, and have achieved five-star ranking”. Emphasizing on the fact that this […]
Last Updates Arylia, AryoGen’s latest product, Denosumab 60 mg effective in controlling and treating various types of osteoporosis Arylia 60 mg in pre-filled syringe Denosumab 60 mg Therapeutic Indications: treatment of postmenopausal osteoporosis in women and also men who have an increased risk of bone fractures Bone loss that results from a reduction in hormone […]
Last Updates FDA Authorizes Tocilizumab for Treatment of COVID-19 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug (tocilizumab) for the treatment of hospitalized adults and pediatric patients (2 years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal […]
Last Updates Biocare launches ‘Temziva’ to defeat Covid-19 BIOCARE Lifesciences Inc. (BLI), a Philippine-based pharmaceutical company announced the launch of the first branded generic of tocilizumab (Temziva) 400mg/20ml solution for infusion. Temziva is approved as a Drug Product for Emergency Use Only (DEU). SRS Life Sciences holds the registration for tocilizumab in the Philippines, while […]
Last Updates Cinnagen’s Corona vaccine received code of ethics Phana: a randomized double-blind two-arm phase II clinical trial was conducted for the study of safety and efficacy of Spikogen ®. This is a recombinant vaccine made by Cinnagen from SARS-Cov2 spike protein. Chief researcher, Payam Tabarsi: Three corona vaccines namely “CovIran Barekat”, “Razi Cov Pars”, […]
Last Updates Tocilizumab improved survival and clinical outcomes in hospitalised COVID-19 patients Data from RECOVERY trial show tocilizumab improved survival and clinical outcomes in hospitalised COVID-19 patients with hypoxia and systemic inflammation Findings published in The Lancet from the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial showed that treatment with tocilizumab improved survival and other […]
Last Updates If the conditions for the mass production of Human Influenza Vaccine are met, this can annually prevent $100 M currency expenditure. Mentioning the unveiling of Human Influenza Vaccine, Vice chairman of Alborz Chamber of Commerce stated: if the conditions for the mass production of this product are met, this can annually prevent $100 […]
Last Updates Dr. Farid Najafi, Research Deputy of Iran’s Ministry of Health visited Aryogen Pharmed Dr. Farid Najafi, Research Deputy of Iran’s Ministry of Health visited Aryogen Pharmed on 3rd March 2021
Last Updates AryoGen Pharmed selected as the green unit in the country AryoGen Pharmed selected as the green unit in the country by Mr. Hakimi, General Manager of Environmental Protection of Alborz Province on 2nd March 2021
Last Updates The opening of the first conference and exhibition of medical biotechnology products and related industries in Iran Olympic Hotel, Tehran 26 to 28 January 2021
